Dr. Christopher Joseph Cosgrove, MD

Dr. Cosgrove practices at Nephrology Associates Inc in East Providence, Rhode Island.

Dr. Cosgrove's NPI, 1558344085, was assigned on November 29, 2005. Dr. Cosgrove graduated from Medical College of Georgia in 1995. Dr. Cosgrove holds Rhode Island license 10940.

Dr. Cosgrove's primary practice is Nephrology Associates Inc, at 318 Waterman Ave, East Providence, RI 02914 in Providence County. The practice phone is (401) 438-5950.

Dr. Cosgrove's primary practice is Nephrology Associates Inc in East Providence, Rhode Island. Dr. Cosgrove is also affiliated with The Miriam Hospital. The medical group on file is Nephrology Associates. Dmand AI also links Dr. Cosgrove to 4 more hospitals and 3 dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cosgrove practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Cosgrove's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Cosgrove is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Cosgrove's licenses on file in 3 states: Rhode Island, Massachusetts and Connecticut.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney cysts among the conditions Dr. Cosgrove treats.

CMS data shows 2,087 Medicare services from Dr. Cosgrove across 12 procedure codes in 2024, for 447 Medicare patients. Medicare paid $165,152 for them.

CMS counts 447 Medicare patients who saw Dr. Cosgrove in 2024. The largest group is 75 to 84, with 180 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 3.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cosgrove's median patient age at 72, with 50% women.

In 2024, Dr. Cosgrove wrote 1,881 Medicare Part D claims for 271 patients. 90% of them were for generic drugs. CMS names the drug for 1,607 of them, across 47 drugs with 11 or more claims each, at $97,990 in total drug cost. In 2023, CMS named 1,310 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Cosgrove for performance year 2024, reported individually. Dr. Cosgrove accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Cosgrove, published from 2020 to 2021. The most frequent topics are COVID-19, Kidney Transplantation and SARS-CoV-2. Dr. Cosgrove's most frequent co-authors are George P. Bayliss, MD, Christopher C. Cosgrove, MD and Reginald Y. Gohh, MD.

CMS Open Payments shows 3 general payments to Dr. Cosgrove from 3 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 99% of the total. Baxter Healthcare paid the most, $108.

Dr. Cosgrove graduated from Medical College of Georgia in 1995.

Dr. Cosgrove is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.